Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLARITHROMYCIN Cause Interstitial lung disease? 41 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Interstitial lung disease have been filed in association with CLARITHROMYCIN (Clarithromycin). This represents 0.2% of all adverse event reports for CLARITHROMYCIN.

41
Reports of Interstitial lung disease with CLARITHROMYCIN
0.2%
of all CLARITHROMYCIN reports
5
Deaths
24
Hospitalizations

How Dangerous Is Interstitial lung disease From CLARITHROMYCIN?

Of the 41 reports, 5 (12.2%) resulted in death, 24 (58.5%) required hospitalization, and 4 (9.8%) were considered life-threatening.

Is Interstitial lung disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLARITHROMYCIN. However, 41 reports have been filed with the FAERS database.

What Other Side Effects Does CLARITHROMYCIN Cause?

Drug ineffective (2,012) Nausea (1,597) Drug hypersensitivity (1,558) Drug interaction (1,288) Diarrhoea (1,228) Dyspnoea (1,151) Malaise (1,131) Headache (1,047) Off label use (944) Vomiting (921)

What Other Drugs Cause Interstitial lung disease?

METHOTREXATE (3,049) RITUXIMAB (2,458) PEMBROLIZUMAB (2,113) PREDNISONE (1,850) CYCLOPHOSPHAMIDE (1,725) NIVOLUMAB (1,538) AMIODARONE (1,421) DOXORUBICIN (1,352) ETANERCEPT (1,267) ADALIMUMAB (1,250)

Which CLARITHROMYCIN Alternatives Have Lower Interstitial lung disease Risk?

CLARITHROMYCIN vs CLARITIN CLARITHROMYCIN vs CLARITIN CHEWABLE CLARITHROMYCIN vs CLARITIN-D-12 CLARITHROMYCIN vs CLARITIN-D-24 CLARITHROMYCIN vs CLARITIN REDITABS

Related Pages

CLARITHROMYCIN Full Profile All Interstitial lung disease Reports All Drugs Causing Interstitial lung disease CLARITHROMYCIN Demographics